Underlying molecular interaction of bovine serum albumin and linezolid: A biophysical outlook.

Related Articles

Underlying molecular interaction of bovine serum albumin and linezolid: A biophysical outlook.

J Biomol Struct Dyn. 2017 Jan 03;:1-40

Authors: Roy A, Seal P, Sikdar J, Banerjee S, Haldar R

Abstract
Linezolid, one of the reserve antibiotic of oxazolidinone class has wide range of antimicrobial activity. Here we have conducted a fundamental study concerning the dynamics of its interaction with bovine serum albumin (BSA), and the post binding modification of the later by employing different spectroscopic (absorption, fluorescence and circular dichroism (CD) spectroscopy) and molecular docking tools. Gradual quenching of the tryptophan (Trp) fluorescence upon addition of linezolid to BSA confirms their interaction. Analysis of fluorescence quenching at different temperature indicates that the interaction is made by static complex formation and the BSA has one binding site for the drug. The negative Gibbs energy change (ΔG(0)), and positive values of enthalpy change (ΔH(0)) and entropy change (ΔS(0)) strongly suggest that it is an entropy driven spontaneous and endothermic reaction. The reaction involves hydrophobic pocket of the protein, which is further stabilized by hydrogen bonding and electrostatic interactions as evidenced from 8-anilino-1-napthalene sulfonic acid, sucrose and NaCl binding studies. From the fluorescence resonance energy transfer (FRET) study, the distance (r) between the donor (Trp of BSA) and acceptor (linezolid) indicates the possibility of high rate of energy transfer. These findings also support the molecular docking study using AutoDock 4.2. The influence of this interaction on the secondary structure of the protein is negligible as evidenced by CD spectroscopy. So, from these findings, we conclude that linezolid interacts with BSA in 1:1 ratio through hydrophobic, hydrogen bonding and ionic interactions, and this may not affect the secondary structure of the protein.

PMID: 28049370 [PubMed - as supplied by publisher]